dsAAV type 2-mediated gene transfer of MORS196A-EGFP into spinal cord as a pain management paradigm.
about
Opioid receptors: toward separation of analgesic from undesirable effectsRapid, long-term labeling of cells in the developing and adult rodent visual cortex using double-stranded adeno-associated viral vectors.Search for the "ideal analgesic" in pain treatment by engineering the mu-opioid receptor.Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene.Intrathecal delivery of a mutant micro-opioid receptor activated by naloxone as a possible antinociceptive paradigm.Naloxone can act as an analgesic agent without measurable chronic side effects in mice with a mutant mu-opioid receptor expressed in different sites of pain pathway.The μ-opioid receptor variant N190K is unresponsive to peptide agonists yet can be rescued by small-molecule drugs.Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant μ-opioid receptor gene in spinal cord.Stereotaxic injection of a viral vector for conditional gene manipulation in the mouse spinal cord.Gene therapy for the treatment of chronic peripheral nervous system pain.AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials.
P2860
Q27002925-9239A2F4-4BF1-41CD-B6E1-58C253D135F7Q30495536-B573FDA6-D54C-490C-875C-F4029A575303Q33807778-8D69D851-B31E-43FC-B302-1EE0FEBB7345Q33907197-2B2E7AB7-CC5F-47A3-9FC2-DE59441A8808Q34128898-953B82ED-50AE-47B5-9731-603BD1EFD186Q34191032-4D234F84-B887-4337-B229-BE3E33C2D814Q34309916-A46A35E2-B61A-46F3-98A4-B5F2558062C7Q34939900-C187433C-651C-422D-B91A-F79136BFCA00Q36804579-F211BE80-AE78-4B75-BDC0-3743B1388880Q38016275-C6AC29A0-F682-48F1-AFC5-2F3FC222CD7EQ47564638-B1F8DD0E-1CE5-42E7-8980-BC8899925A16
P2860
dsAAV type 2-mediated gene transfer of MORS196A-EGFP into spinal cord as a pain management paradigm.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
dsAAV type 2-mediated gene tra ...... as a pain management paradigm.
@ast
dsAAV type 2-mediated gene tra ...... as a pain management paradigm.
@en
type
label
dsAAV type 2-mediated gene tra ...... as a pain management paradigm.
@ast
dsAAV type 2-mediated gene tra ...... as a pain management paradigm.
@en
prefLabel
dsAAV type 2-mediated gene tra ...... as a pain management paradigm.
@ast
dsAAV type 2-mediated gene tra ...... as a pain management paradigm.
@en
P2093
P2860
P356
P1476
dsAAV type 2-mediated gene tra ...... as a pain management paradigm.
@en
P2093
P2860
P304
20096-20101
P356
10.1073/PNAS.0703409104
P407
P577
2007-12-04T00:00:00Z